IRadimed Financial Statements From 2010 to 2026

Stocks . Germany . 
Stock . IRadimed
46K Stock   83.50  3.00  3.47%   
Analyzing historical trends in various income statement and balance sheet accounts from IRadimed's financial statements helps investors evaluate the company's valuation, profitability, and current liquidity needs. Key fundamental drivers impacting IRadimed's valuation are summarized below:
Gross Profit
64.3 M
Profit Margin
0.2682
Market Capitalization
1.1 B
Enterprise Value Revenue
14.5477
Revenue
83.8 M
There are currently sixty-seven fundamental trends for IRadimed that can be evaluated and compared over time across competitors. All traders should confirm IRadimed's regular fundamentals against the performance from 2010 to 2026 and make sure the trends continue to evolve in the right direction.

IRadimed Total Revenue

47.69 Million

Check IRadimed financial statements over time to gain insight into future company performance. You can evaluate financial statements to find patterns among IRadimed's main balance sheet or income statement drivers, such as Tax Provision of 6.1 M, Net Interest Income of 2.6 M or Interest Income of 2.6 M, as well as many indicators such as . IRadimed financial statements analysis is a perfect complement when working with IRadimed Valuation or Volatility modules.
  
This module can also supplement various IRadimed Technical models . Check out the analysis of IRadimed Correlation against competitors.

IRadimed Balance Sheet

Trends
Current ValueLast YearHistorical Average 10 Year Trend
Total Assets75.9 M113.1 M60.8 M
Slightly volatile
Other Current Liabilities128.2 K135 K1.5 M
Pretty Stable
Total Current Liabilities7.8 M9.8 M6.1 M
Slightly volatile
Total Stockholder Equity64.5 M99.8 M52 M
Slightly volatile
Other Liabilities1.5 M1.2 M1.7 M
Pretty Stable
Net Tangible Assets56.9 M82.3 M48.8 M
Slightly volatile
Retained Earnings41 M65.3 M33 M
Slightly volatile
Accounts Payable1.3 M2.2 M1.2 M
Slightly volatile
Cash46.4 M60.1 M34.8 M
Slightly volatile
Non Current Assets Total27.9 M26.5 M8.9 M
Slightly volatile
Non Currrent Assets Other217.3 K228.7 K468.9 K
Pretty Stable
Other Assets1.4 M1.6 M1.2 M
Slightly volatile
Net Receivables7.9 M12.1 M6.3 M
Slightly volatile
Non Current Liabilities Total3.7 M3.4 M2.8 M
Slightly volatile
Inventory6.4 M12 M5.5 M
Slightly volatile
Other Current Assets1.5 M2.4 M1 M
Slightly volatile
Total Liabilities11.4 M13.2 M8.8 M
Slightly volatile
Total Current Assets66.1 M86.5 M52.8 M
Slightly volatile
Intangible Assets3.7 M3.6 M1.5 M
Slightly volatile
Common Stock1.3 K1.4 K1.2 K
Slightly volatile
Property Plant Equipment3.8 M5.3 M3 M
Slightly volatile
Common Stock Shares Outstanding13.2 M14.6 M11.6 M
Slightly volatile
Net Invested Capital68.2 M99.8 M52.6 M
Slightly volatile
Net Working Capital61.6 M76.7 M47.3 M
Slightly volatile
Capital Stock1.3 K1.5 K1.2 K
Slightly volatile
Property Plant And Equipment Net20.5 M19.5 M7.7 M
Slightly volatile
Capital Lease Obligations132.3 K139.2 K2.3 M
Slightly volatile
Property Plant And Equipment Gross26 M24.8 M9.1 M
Slightly volatile

IRadimed Income Statement

Trends
Current ValueLast YearHistorical Average 10 Year Trend
Net Interest Income2.6 M2.5 M683 K
Slightly volatile
Interest Income2.6 M2.5 M683 K
Slightly volatile
Selling General Administrative23.1 M36.3 M19.6 M
Slightly volatile
Total Revenue47.7 M84.2 M42.2 M
Slightly volatile
Gross Profit36.7 M64.8 M32.9 M
Slightly volatile
Net Income From Continuing Ops23.2 M22.1 M10.1 M
Slightly volatile
EBIT18.9 M18 M11.2 M
Slightly volatile
Research Development2.2 M3.3 M1.8 M
Slightly volatile
Cost Of Revenue11 M19.4 M9.3 M
Slightly volatile
Total Operating Expenses36.3 M59 M30.7 M
Slightly volatile
Net Income Applicable To Common Shares7.4 M14.8 M8.1 M
Slightly volatile
Net Income23.2 M22.1 M10.1 M
Slightly volatile
EBITDA6.9 M12.9 M6.1 M
Slightly volatile
Reconciled Depreciation865.5 K735.9 K1.1 M
Slightly volatile

IRadimed Cash Flow Statement

Trends
Current ValueLast YearHistorical Average 10 Year Trend
Other Cashflows From Financing Activities482.8 K543.2 K592.9 K
Slightly volatile
Capital Expenditures10.6 M10.1 M3 M
Slightly volatile
Total Cash From Operating Activities30.9 M29.5 M12.5 M
Slightly volatile
Net Income23.2 M22.1 M10.1 M
Slightly volatile
End Period Cash Flow46 M60.1 M34.6 M
Slightly volatile
Change To Netincome2.3 M1.8 M1.6 M
Slightly volatile
Free Cash Flow20.3 M19.3 M7.2 M
Slightly volatile
Begin Period Cash Flow44.7 M57.2 M32.4 M
Slightly volatile
Stock Based Compensation1.8 M2.3 M2 M
Pretty Stable
Dividends Paid14.1 M15.7 M12.9 M
Slightly volatile

IRadimed Fundamental Market Drivers

About IRadimed Financial Statements

IRadimed shareholders use historical fundamental indicators, such as revenue or net income, to determine how well the company is positioned to perform in the future. Although IRadimed investors may analyze each financial statement separately, they are all interrelated. The changes in IRadimed's assets and liabilities, for example, are also reflected in the revenues and expenses on on IRadimed's income statement. Understanding these patterns can help investors time the market effectively. Please read more on our fundamental analysis page.
Last ReportedProjected for Next Year
Total Revenue84.2 M47.7 M
Cost Of Revenue19.4 M11 M

Thematic Opportunities

Explore Investment Opportunities

Build portfolios using Macroaxis predefined set of investing ideas. Many of Macroaxis investing ideas can easily outperform a given market. Ideas can also be optimized per your risk profile before portfolio origination is invoked. Macroaxis thematic optimization helps investors identify companies most likely to benefit from changes or shifts in various micro-economic or local macro-level trends. Originating optimal thematic portfolios involves aligning investors' personal views, ideas, and beliefs with their actual investments.
Explore Investing Ideas  

Additional Tools for IRadimed Stock Analysis

When running IRadimed's price analysis, check to measure IRadimed's market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy IRadimed is operating at the current time. Most of IRadimed's value examination focuses on studying past and present price action to predict the probability of IRadimed's future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move IRadimed's price. Additionally, you may evaluate how the addition of IRadimed to your portfolios can decrease your overall portfolio volatility.
Macroaxis helps investors of all levels and skills to maximize the upside of all their holdings and minimize the risk associated with market volatility, economic swings, and company-specific events. View terms and conditions
 
Feedback Blog
Made with optimal in San Francisco
2026 Macroaxis LLC
COMMON DESTINATIONS
MAIN CATEGORIES
COMPANY